contraindications for glp-1 glp 1 receptor agonists Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus Contraindications, warnings, and precautions of

A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist

The primary endpoint, which was the relative reduction in magnetic resonance imaging-proton density fat fraction (MRI-PDFF) assessed hepatic fat, was achieved with a placebo-adjusted difference of 29%

PlexusDx Precision Peptide Genetic Test maps 14 metabolic and immune pathways, including variants in genes like MC4R (rs17782313) and GLP1R (rs6923761), which affect how your body processes these medications and regulates inflammation

The Overlooked Connection: Dysbiosis and Degenerative Disease Degenerative musculoskeletal diseases, including osteoarthritis (OA), osteoporosis (OP), sarcopenia (SP), and intervertebral disc degeneration (IVDD), affect well over a billion people globally and share three core pathological features: chronic inflammation, oxidative stress, and dysregulated cell death

What Research Says about GLP-1 A 2015 study in the Annals of Internal Medicine found: Increasing fiber intake alone may be sufficient for weight loss. Several publications and Research in JAMA discusses how GLP-1 receptor agonists increase satiety and slow digestion

Tirzepatide's Double Punch Many weight loss medications target a single pathway